Application

16625990 · IBANDRONATE CONJUGATES OF NUCLEOSIDE ANTIMETABOLITES

Filed 2019-12-23 · Granted · Patent 11298366 (2022-04-12) The official file ↗The patent and its PDF ↗ · Art unit 1623 · Examiner Leigh C Maier Typical · CPC A61K 31/663 · MBC Pharma, Inc. · MBC Pharma

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

11.9 mo

to disposition 27.6 mo

Statutes raised

103

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.